Fuse demonstrated strong financial performance in the second quarter of 2023, highlighted by a 7% increase in revenue, a 31% increase in gross profit, and a $648,408 increase in EBITDA over the prior-year period. The company pursues growth through expanding its portfolio of proprietary branded and manufactured products, targeting hospitals, medical facilities, and sub-distributors across the US market.
Cyborg Score Rationale
As a small-cap OTC public company, Fuse has limited liquidity and visibility but demonstrates operational improvements. The company shows traction with proprietary product launches (Orbitum™ Compression Staple System launched in August 2021, FuseChoice™ Dermal Matrix in September 2021) and positive EBITDA trends in 2023. However, minimal recent press releases beyond 2023 and OTC trading status signal challenges in capital access and market recognition.
Top Insights
Product Portfolio Diversification: Company maintains a broad product range spanning spine fusion, joint reconstruction, sports medicine, trauma fixation, biologics, and regenerative medicine—reducing single-product risk.
Revenue Scale: As of fiscal year 2021, recorded $20.4 million in revenue, placing the company as rank 149 among DFW's largest public companies (August 2022 announcement).
Strategic Product Launches: Launched proprietary Orbitum™ Compression Staple System (August 2021) and FuseChoice™ Dermal Matrix (September 2021) to drive branded manufacturing capabilities.
OTC Liquidity Constraint: Trading on OTC Pink Markets limits institutional access, institutional investor participation, and capital-raising options relative to NASDAQ/NYSE peers.
Named Competitors
Orthopedic Implants & Reconstruction — Global leader in musculoskeletal care products and solutions
Trauma & Spine Surgery Devices — Innovator in trauma, spine, orthopedics, and surgical technology
Spine & Biologics — Leading global spine, biological, and regenerative surgery solutions provider
Orthopedic & Spine Distribution — Regional orthopedic and trauma device distributor